Osteoclast-mediated osteolysis in bone metastasis from renal cell carcinoma.
Osteolytic characteristics of bone metastasis from renal cell carcinoma were morphologically and biochemically investigated. First, undecalcified ground sections of bone metastases were made from four patients with renal cell carcinoma. Second, renal cell carcinoma cell line (RCC-K1) was established from one of the four patients, and its effect on bone resorption in vitro was examined. Marked proliferation and activation of osteoclasts around the tumor cells was histologically demonstrated. Conditioned medium from the RCC-K1 cells contained potent bone-resorbing activity in vitro. The activity was reduced to basal level by calcitonin, but was not blocked by indomethacin. The activity was lost after dialysis (MW cutoff 3500), while it was retained after 2 weeks of storage. Levels of prostaglandin E2 and 1,25-dihydroxyvitamin D of the RCC-K1-conditioned medium were insufficient to cause bone resorption in vitro. The conditioned medium did not stimulate cAMP accumulation in rat osteoblastic cells. These results suggest that renal cell carcinoma causes bone destruction through the stimulation of osteoclasts by locally secreting an unknown humoral factor or factors.
Aoki
J
J
Department of Radiology and Nuclear Medicine, Kyoto University School of Medicine, Japan.
Yamamoto
I
I
Hino
M
M
Shigeno
C
C
Kitamura
N
N
Sone
T
T
Shiomi
K
K
Konishi
J
J
D000368:Aged; D001859:Bone Neoplasms / Q000556:secondary*; D001862:Bone Resorption; D002292:Carcinoma, Renal Cell / Q000378:metabolism*; D046508:Culture Techniques; D006801:Humans; D007680:Kidney Neoplasms / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010010:Osteoclasts / Q000473:pathology; D010014:Osteolysis / Q000209:etiology*